Ipca Laboratories gets revision in ratings for bank facilities
From CRISIL
Ipca Laboratories has received revision in ratings for the bank facilities aggregating Rs 1182.5 crore of the Company from CRISIL.Long term rating - CRISIL AA-/ Stable (Downgraded from CRISIL AA/ Negative)
Rs 15 crore NCDs - CRISIL AA-/ Stable (Downgraded from CRISIL AA/ Negative)
Rs 50 crore Short term debt - CRISIL A1+ (Reaffirmed)
Powered by Capital Market - Live News
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 29 2016 | 3:47 PM IST